Article
KRAS G12C mutated advanced non-small cell lung cancer (NSCLC): Characteristics, treatment patterns and overall survival from a Danish nationwide observational register study.
Lung cancer (Amsterdam, Netherlands) - 1 Apr 2023
Frost Matilde Grupe, Jensen Kristoffer Jarlov, Gotfredsen Ditte Resendal, Sørensen Anne Mette Skov, Ankarfeldt Mikkel Zöllner, Louie Karly S, Sroczynski Nicholas, Jakobsen Erik, Andersen Jon Lykkegaard, Jimenez-Solem Espen, Petersen Tonny Studsgaard
Abstract excerpt
OBJECTIVES: We aimed to characterize the advanced NSCLC population in terms of KRAS G12C prevalence, patient characteristics, and survival outcomes after the introduction of immunotherapies. MATERIALS AND METHODS: We identified adult patients diagnosed with advanced NSCLC between January 1, 2018 and June 30, 2021 using the Danish health registries. Patients were grouped by mutational status (any KRAS mutation,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.